Last update 01 Nov 2024
BCG(Verity)
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Oncolytic bacteria |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization  Verity Pharmaceuticals, Inc.Startup |
Active Organization Verity Pharmaceuticals, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CA (24 Dec 2020), |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with BCG(Verity)A Multicenter, Randomized, Double-blind, Controlled Phase III Non-inferiority Study Assessing Efficacy and Safety of VERITY-BCG in Management of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC) in BCG-naïve Patients.
100 Clinical Results associated with BCG(Verity)
Login to view more data
100 Translational Medicine associated with BCG(Verity)
Login to view more data
100 Patents (Medical) associated with BCG(Verity)
Login to view more data
100 Deals associated with BCG(Verity)
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Non-Muscle Invasive Bladder Neoplasms | CA | Verity Pharmaceuticals, Inc.Startup | 24 Dec 2020 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Muscle Invasive Bladder Neoplasms | Phase 3 | - | Verity Pharmaceuticals, Inc.Startup | 01 Jan 2023 |
| Non-Muscle Invasive Bladder Urothelial Carcinoma | Phase 3 | - | Verity Pharmaceuticals, Inc.Startup | 01 Jan 2023 |
| Recurrent Bladder Cancer | Phase 3 | - | Verity Pharmaceuticals, Inc.Startup | 01 Jan 2023 |
| Recurrent Carcinoma | Phase 3 | - | Verity Pharmaceuticals, Inc.Startup | 01 Jan 2023 |
| Urothelial carcinoma recurrent | Phase 3 | - | Verity Pharmaceuticals, Inc.Startup | 01 Jan 2023 |
| Bladder Cancer | Phase 2 | US | Verity Pharmaceuticals, Inc.Startup | 22 Dec 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free